Antigen presentation by major histocompatibility complex (MHC) class I molecules requires peptide supply by the transporters associated with antigen processing (TAPs), which select substrates in a species- and, in the rat, allele-specific manner. Conflicts between TAPs and MHC preferences for COOH-terminal peptide residues in rodent cells strongly reduce the efficiency of MHC class I antigen presentation. Although human TAP is relatively permissive, some peptide ligands for human histocompatibility leukocyte antigen class I molecules are known to possess very low TAP affinities; the significance of these in vitro findings for cellular antigen presentation is not known. We studied two naturally immunodominant viral epitopes presented by HLA-A2 that display very low affinities for human TAP. Low TAP affinities preclude minimal epitope access to the endoplasmic reticulum (ER) and assembly with HLA-A2 in vitro, as well as presentation by minigene-expressing cells to cytotoxic T lymphocytes. However, NH2-terminally but not COOH-terminally extended epitope variants with higher TAP affinities assemble in vitro and are presented to cytotoxic T lymphocytes with high efficiency. Thus, human TAP can influence epitope selection and restrict access to the ER to epitope precursors. Analysis of TAP affinities of a panel of viral epitopes suggests that TAP selection of precursors may be a common phenomenon for HLA-A2–presented epitopes. We also analyzed HLA-A2–eluted peptides from minigene-expressing cells and show that an NH2-terminally extended variant with low A2 binding affinity undergoes ER processing, whereas another with high affinity is presented unmodified. Therefore, the previously reported aminopeptidase activity in the ER can also act on TAP-translocated peptides.
Skip Nav Destination
Article navigation
1 November 1999
Article|
November 01 1999
Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells
Grégoire Lauvau,
Grégoire Lauvau
aInstitut National de la Santé et Recherche Medicale (INSERM) U25, Hôpital Necker, 75015 Paris, France
Search for other works by this author on:
Kazuhiro Kakimi,
Kazuhiro Kakimi
bScripps Research Institute, La Jolla, California 92037
Search for other works by this author on:
Gabriele Niedermann,
Gabriele Niedermann
cMax-Planck-Institut für Immunbiologie, D-79108 Freiburg, Germany
Search for other works by this author on:
Marina Ostankovitch,
Marina Ostankovitch
dINSERM U455, ICGM, 75014 Paris, France
Search for other works by this author on:
Patricia Yotnda,
Patricia Yotnda
eInstitut Pasteur, Département SIDA-Rétrovirus, Unité d'Immunité Cellulaire Antivirale, 75724 Paris cedex 15, France
Search for other works by this author on:
Hüseyin Firat,
Hüseyin Firat
eInstitut Pasteur, Département SIDA-Rétrovirus, Unité d'Immunité Cellulaire Antivirale, 75724 Paris cedex 15, France
Search for other works by this author on:
Francis V. Chisari,
Francis V. Chisari
bScripps Research Institute, La Jolla, California 92037
Search for other works by this author on:
Peter M. van Endert
Peter M. van Endert
aInstitut National de la Santé et Recherche Medicale (INSERM) U25, Hôpital Necker, 75015 Paris, France
Search for other works by this author on:
Grégoire Lauvau
aInstitut National de la Santé et Recherche Medicale (INSERM) U25, Hôpital Necker, 75015 Paris, France
Kazuhiro Kakimi
bScripps Research Institute, La Jolla, California 92037
Gabriele Niedermann
cMax-Planck-Institut für Immunbiologie, D-79108 Freiburg, Germany
Marina Ostankovitch
dINSERM U455, ICGM, 75014 Paris, France
Patricia Yotnda
eInstitut Pasteur, Département SIDA-Rétrovirus, Unité d'Immunité Cellulaire Antivirale, 75724 Paris cedex 15, France
Hüseyin Firat
eInstitut Pasteur, Département SIDA-Rétrovirus, Unité d'Immunité Cellulaire Antivirale, 75724 Paris cedex 15, France
Francis V. Chisari
bScripps Research Institute, La Jolla, California 92037
Peter M. van Endert
aInstitut National de la Santé et Recherche Medicale (INSERM) U25, Hôpital Necker, 75015 Paris, France
1used in this paper: β2m, β2-microglobulin; BFA, brefeldin A; Ct, COOH-terminal; ER, endoplasmic reticulum; HBV, hepatitis B virus; HCI, HLA class I; HCV, hepatitis C virus; MOI, multiplicity of infection; Nt, NH2-terminal; TAPs, transporters associated with antigen processing
Received:
October 30 1998
Revision Requested:
July 26 1999
Accepted:
August 26 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 1999 The Rockefeller University Press
1999
The Rockefeller University Press
J Exp Med (1999) 190 (9): 1227–1240.
Article history
Received:
October 30 1998
Revision Requested:
July 26 1999
Accepted:
August 26 1999
Citation
Grégoire Lauvau, Kazuhiro Kakimi, Gabriele Niedermann, Marina Ostankovitch, Patricia Yotnda, Hüseyin Firat, Francis V. Chisari, Peter M. van Endert; Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells. J Exp Med 1 November 1999; 190 (9): 1227–1240. doi: https://doi.org/10.1084/jem.190.9.1227
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement